Real-time enrollment status for this digestive system neuroendocrine neoplasm clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:14 PM UTC
| NCT Number | NCT06202066 |
| Recruiting Status | Recruiting |
| Condition | Digestive System Neuroendocrine Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Roswell Park Cancer Institute |
| Last Updated on CT.gov | May 28, 2026 (May 28, 2026) |
As of July 19, 2026: Clinical trial NCT06202066 is currently recruiting participants. This phase2 study for digestive system neuroendocrine neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by Roswell Park Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06202066 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06202066 was last updated May 28, 2026 (May 28, 2026). HelloStudys verifies this status automatically.